DRTSAlpha Tau Medical Ltd.

DRTS Stock Price, Valuation & Chart | Alpha Tau Medical Ltd.

Compare

$14.330+0.37 (+2.65%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology DRTS intrinsic value DRTS calculated fair value vs price

Overview Financials Dividends Ratios

DRTS Historical price chart

DRTS Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.29B

PE Ratio-13.78

EPS-1.04

Trading Volume372.32K

Today's High/Low14.65/13.88

Dividend Yield0.00

52 Week High/Low15.1/3.35

Shares Outstanding90.33M

DRTS Financial Statement

DRTS Analyst ratings

DRTS Analysis & performance metrics

DRTS Company profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy…

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic…

DRTS Management team

Name

Position

Peter M. Melnyk

Chief Commercial Officer

Raphi LevyCFO

Chief Financial Officer

Amnon Gat

Chief Operations Officer

Ronen SegalCTO

Chief Technology Officer

Robert B. Den M.D.

Chief Medical Officer & Member of Scientific Advisory Board

Yona Keisari

Chief Scientific Officer & Member of Scientific Advisory board

Yael Zeiger

Corporate Controller

Rebecca Becker

Vice President of legal

Name

Position

Peter M. Melnyk

Chief Commercial Officer

Raphi LevyCFO

Chief Financial Officer

Amnon Gat

Chief Operations Officer

Ronen SegalCTO

Chief Technology Officer

Robert B. Den M.D.

Chief Medical Officer & Member of Scientific Advisory Board

Yona Keisari

Chief Scientific Officer & Member of Scientific Advisory board

Yael Zeiger

Corporate Controller

Rebecca Becker

Vice President of legal

Management Team

Peter M. Melnyk

Chief Commercial Officer

Raphi LevyCFO

Chief Financial Officer

Amnon Gat

Chief Operations Officer

Ronen SegalCTO

Chief Technology Officer

Robert B. Den M.D.

Chief Medical Officer & Member of Scientific Advisory Board

Yona Keisari

Chief Scientific Officer & Member of Scientific Advisory board

Yael Zeiger

Corporate Controller

Rebecca Becker

Vice President of legal

Management

Peter M. Melnyk

Chief Commercial Officer

Raphi LevyCFO

Chief Financial Officer

Amnon Gat

Chief Operations Officer

Ronen SegalCTO

Chief Technology Officer

Robert B. Den M.D.

Chief Medical Officer & Member of Scientific Advisory Board

Yona Keisari

Chief Scientific Officer & Member of Scientific Advisory board

Yael Zeiger

Corporate Controller

Rebecca Becker

Vice President of legal

Total 8 executives

DRTS Frequently asked questions

What is Alpha Tau Medical Ltd. (DRTS) Stock Price?

Current stock price of Alpha Tau Medical Ltd. (DRTS) stock is $14.330. The stock price is +2.65% higher in the session. The intraday range can be seen from this page. Volume of Alpha Tau Medical Ltd. (DRTS) stock is 372.32K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Alpha Tau Medical Ltd. (DRTS) stock price going up or down today?

The stock price of Alpha Tau Medical Ltd. (DRTS) can change with earnings, company news, and overall market sentiment. Alpha Tau Medical Ltd. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Alpha Tau Medical Ltd. stock expensive at its current price?

Whether Alpha Tau Medical Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for DRTS on this page is -13.78. EPS on this page is -1.04. Compare those figures with peers and growth expectations before deciding if the current Alpha Tau Medical Ltd. price is justified.

How has the stock price of Alpha Tau Medical Ltd. (DRTS) performed historically?

Historical performance for Alpha Tau Medical Ltd. (DRTS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how DRTS reacted to past earnings and market events.

Should I buy Alpha Tau Medical Ltd. (DRTS) stock, at this price?

Buying Alpha Tau Medical Ltd. (DRTS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.